Data Horizon Co Ltd
Data Horizon Co Ltd designs, develops, and sells medical equipment and related software solutions for diagnostic and therapeutic applications in the healthcare industry.
Business. Data Horizon Co Ltd (3628.T) is a Japanese company engaged in the healthcare equipment industry, specifically within the advanced medical equipment and technology sector. The firm operates primarily through a product-sale revenue model, focusing on the development and distribution of medical devices. Headquartered in Japan, the company is listed on the Tokyo Stock Exchange. Specific details regarding operating segments or geographic revenue breakdowns are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Data Horizon Co Ltd (3628.T) is a Japanese company engaged in the healthcare equipment industry, specifically within the advanced medical equipment and technology sector. The firm operates primarily through a product-sale revenue model, focusing on the development and distribution of medical devices. Headquartered in Japan, the company is listed on the Tokyo Stock Exchange. Specific details regarding operating segments or geographic revenue breakdowns are not available.
Data Horizon Co Ltd has a market price of ¥639 per share, translating to a market capitalization of ¥8.11 billion. The company's price-to-book ratio is 2.32, and its price-to-tangible-book ratio is also 2.32, indicating that the market is valuing the company at a premium to its book value. The enterprise value to EBITDA ratio is negative at -1788.91, reflecting the company's current operating losses. The enterprise value to revenue ratio is 7.0, suggesting that the company is trading at a multiple of 7 times its revenue.
The company's profitability metrics are concerning. The return on equity is -2.29%, and the return on assets is -0.91%, both indicating a negative return on invested capital. The gross profit margin is 35.15% (¥573.04 million / ¥1.63 billion), which is relatively high for a medical equipment company, but the operating loss of ¥6.38 million and net loss of ¥80.01 million suggest significant cost pressures or operational inefficiencies.
Data Horizon Co Ltd's revenue is concentrated in a single business segment, as disclosed in its financial statements. The company does not provide geographic revenue breakdowns, but its operations are primarily based in Japan, with no material international revenue disclosed. This lack of geographic diversification could expose the company to regional economic or regulatory risks.
The company's growth trajectory is uncertain. Revenue for the latest period is ¥1.63 billion, but there is no disclosed prior period data to assess year-over-year growth. The company is currently operating at a loss, and without a clear path to profitability or significant revenue growth, its long-term growth prospects are unclear.
The company's liquidity position is medium risk, with a current ratio of 0.93, indicating that it has slightly more current liabilities than current assets. The debt-to-equity ratio is 1.21, suggesting that the company is leveraged, with ¥4.24 billion in long-term debt compared to ¥3.496 billion in equity. The risk assessment indicates that the company has negative net cash after subtracting total debt, which could limit its financial flexibility. The dilution risk is currently low, with no significant dilution expected in the near term.
There are no recent events or filings disclosed in the provided data that would indicate significant changes in the company's operations or financial position. The company's financial statements do not mention any recent strategic initiatives, product launches, or regulatory changes that could impact its future performance.
- Data Horizon Co Ltd is currently operating at a loss, with a net loss of ¥80.01 million and an operating loss of ¥6.38 million.
- The company's market valuation is at a premium to book value, with a price-to-book ratio of 2.32.
- The company's liquidity position is weak, with a current ratio of 0.93 and a debt-to-equity ratio of 1.21.
- The company's profitability metrics are negative, with a return on equity of -2.29% and a return on assets of -0.91%.
- The company's revenue is concentrated in a single business segment, with no material international revenue disclosed.
- The company's growth trajectory is uncertain, with no disclosed prior period data to assess year-over-year growth.
Bull / Bear case
Generated · model-assistedRevenue grew at a 3.7% CAGR over four years, showing modest top-line expansion despite recent volatility.
Dilution risk is assessed as low, providing some stability for existing shareholders regarding equity structure.
Long-term debt surged to 4.81 billion JPY, more than doubling from the prior year and increasing financial leverage significantly.
The company faces high credit risk, raising concerns about its ability to meet financial obligations and service debt.
Debt-to-equity ratio of 1.21 places the company in the bottom quartile of its cohort, indicating excessive leverage.
In focus — financials by report
Revenue ¥1.42B, +28,7% YoY; Operating income +157,4% YoY.
- ▍Revenue ¥1.42B, +28,7% YoY
- ▍Operating income +157,4% YoY
- ▍Net income +159,1% YoY
- ▍Net margin 10.5%
Revenue ¥1.10B, +1,4% YoY; Operating income +100,0% YoY.
- ▍Revenue ¥1.10B, +1,4% YoY
- ▍Operating income +100,0% YoY
- ▍Net income +98,9% YoY
- ▍Net margin -0.3%
Revenue ¥991.2M, −1,3% YoY; Operating income +86,3% YoY.
- ▍Revenue ¥991.2M, −1,3% YoY
- ▍Operating income +86,3% YoY
- ▍Net income +81,9% YoY
- ▍Net margin -5.6%
Revenue ¥1.67B, +2,5% YoY; Operating income −37 010,3% YoY.
- ▍Revenue ¥1.67B, +2,5% YoY
- ▍Operating income −37 010,3% YoY
- ▍Net income −2 889,6% YoY
- ▍Net margin -143.1%
Revenue ¥1.10B; Operating income -¥264.1M.
- ▍Revenue ¥1.10B
- ▍Operating income -¥264.1M
- ▍Net margin -23.0%
Revenue ¥1.08B; Operating income -¥348.2M.
- ▍Revenue ¥1.08B
- ▍Operating income -¥348.2M
- ▍Net margin -29.6%
Revenue ¥1.00B; Operating income -¥380.8M.
- ▍Revenue ¥1.00B
- ▍Operating income -¥380.8M
- ▍Net margin -30.6%
Revenue ¥1.63B; Operating income -¥6.4M.
- ▍Revenue ¥1.63B
- ▍Operating income -¥6.4M
- ▍Net margin -4.9%
Revenue ¥5.01B, +13,5% YoY; Operating income −33,7% YoY.
- ▍Revenue ¥5.01B, +13,5% YoY
- ▍Operating income −33,7% YoY
- ▍Net income −21,4% YoY
- ▍Free cash flow −0,5% YoY
- ▍Net margin -16.1%
Revenue ¥4.41B, +47,5% YoY; Operating income −70,2% YoY.
- ▍Revenue ¥4.41B, +47,5% YoY
- ▍Operating income −70,2% YoY
- ▍Net income −61,9% YoY
- ▍Free cash flow −10,7% YoY
- ▍Net margin -15.1%
Revenue ¥2.99B, −10,2% YoY; Operating income −210,2% YoY.
- ▍Revenue ¥2.99B, −10,2% YoY
- ▍Operating income −210,2% YoY
- ▍Net income −244,7% YoY
- ▍Free cash flow −1 928,1% YoY
- ▍Net margin -13.7%
Revenue ¥3.33B; Operating income ¥334.8M.
- ▍Revenue ¥3.33B
- ▍Operating income ¥334.8M
- ▍Net margin 8.5%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- Data Horizon Co Ltd Market data — financials · 2026-05-26